Professional Documents
Culture Documents
Shock
Key Points
Shock : A failure to meet the metabolic demands of
cells & tissues
Shock :
Decreased tissue perfusion
Secondary to elaborated or released products
Physiologic responses to shock are neuroendocrine,
metabolic, and immune/inflammatory signaling
Key Points
Treatment of hemorrhagic shock is volume
resuscitation, timely control of bleeding is influences
outcome
Prevention of hypothermia, acidemia, and
coagulopathy are essential in hemorrhagic shock
Treatment of septic shock is fluid resuscitation,
appropriate antibiotic and control the source of
infection
A parameters of organ/tissue perfusion are used to
determine and follow the efficacy of resuscitation
"Shock is the manifestation of the rude unhinging of
the machinery of life."
Samuel V. Gross, 1872
EVOLUTION IN
UNDERSTANDING SHOCK
Overview
Shock is the failure to meet the metabolic needs of
the cell
The injury (Cell/Tissue/Organ damage)
The initial Æ Reversible
If prolonged or severe enough Æ Irreversible
Understanding of shock Æ The knowledge of
physiology and pathophysiology throughout the 20th
century
This includes the sympathetic and neuroendocrine
stress responses on the cardiovascular system
Overview
The clinical manifestations are lead to diagnosis and
management of patients in shock
However, BP and HR are relatively insensitive
measures of shock
Additional considerations must be used to help aid in
early diagnosis and treatment of shock
The general management in shock :
Assuring a secure airway with adequate ventilation
Restoration of vascular volume and tissue perfusion.
Historical Background
Claude Bernard :
The organism attempts to maintain constancy against
external forces that attempt to disrupt “milieu interieur”
Walter B. Cannon : World War I
An organism's ability to survive Æ maintenance of
“homeostasis”
“Fight or Flight response”
The initial of Shock Æ A disturbance of the nervous system
that resulted in vasodilatation and hypotension
Secondary shock Æ “toxic factor” with its attendant
capillary permeability leak
Historical Background
Alfred Blalock
In hemorrhagic shock was associated with
reduced cardiac output due to volume loss, not a
"toxic factor"
In 1934 : Four categories of shock
• Hypovolemic shock
• Vasogenic shock
• Cardiogenic shock
• Neurogenic shock
Historical Background
This Categorization of shock based on etiology persists today
Wiggers : In 1947
Developed a irreversible model of hemorrhagic shock
based on uptake of shed blood into a reservoir to maintain
a set level of hypotension
G. Tom Shires
Demonstrating a large ECF deficit, greater than vascular
refilling alone occurred in severe hemorrhagic shock
The phenomenon of fluid redistribution after major
trauma involving blood loss was termed third space
loss
Historical Background
During the Vietnam War :
Aggressive fluid resuscitation with RBC and crystalloid or
plasma Æ ↑survival of patients & ↓Renal failure
However, a new disease process, acute fulminant
pulmonary failure, appeared as an early cause of death Æ
DaNang lung or shock lung
The clinical problem became recognized as acute
respiratory distress syndrome (ARDS).
Our current concept of ARDS is a component in the
spectrum of multiple organ system failure
Historical Background
Restoration of BP prior to control of active bleeding may
result in loss of blood that is sorely needed
Challenged the appropriate endpoints in resuscitation of
uncontrolled hemorrhage
Core principles in the management of the critically ill or
injured patient
(a) definitive control of the airway must be secured
(b) control of active hemorrhage must occur promptly
(c) volume resuscitation with RBC, plasma, and crystalloid must occur
while operative control of bleeding is achieved
(d) unrecognized or inadequately corrected hypoperfusion increases
morbidity and mortality
Current Definitions and Challenges
Shock consists of inadequate tissue perfusion
Failure of oxidative metabolism that can involve defects of
O2 (delivery/transport/ utilization)
Current challenges
Endpoints of tissue oxygenation
Using therapeutic strategies at the cellular/molecular
Compensated pt. or pt. early in course of disease
Initiate appropriate treatment
Evaluation efficacy of resuscitation and adjuncts.
Pathophysiology of Shock
Pathophysiology of Shock
Pathophysiology of Shock
Neuroendocrine and Organ-Specific
Responses to Hemorrhage
Goal Æ maintain perfusion to the heart and brain
Mechanisms
Cardiovascular response
Hormonal response
Circulatory homeostasis
The initial stimulus Æ loss of circulating blood
volume in hemorrhagic shock.
The magnitude response is based on both the
volume and the rate of blood lost
Afferent Signals
Baroreceptors
Atrium : activated with low volume hemorrhage or mild
reductions in right atrial pressure
Aortic arch and carotid bodies : responding to larger
reductions in intravascular volume or pressure
Inhibit induction of the ANS Æ producing centrally
mediated constriction of peripheral vessels.
Chemoreceptors
Aorta and carotid bodies are sensitive to changes in (O2/
H+/CO2)
Results in vasodilation of the coronary arteries, ↓ HR, and
vasoconstriction of the splanchnic and skeletal circulation
Efferent Signals
Cardiovascular Response
⊕ α‐adrenergic receptors Ævasoconstriction
↑Catecholamine Æ↑glycogenolysis +↑gluconeogenesis
+↓insulin +↑glucagon
Efferent Signals
Hormonal Response
Stress Î ⊕ HPA axis Æ CRH Æ↑ACTH Æ ↑Cortisol
Cortisol : (Hyperglycemia + Proteolysis + Lipolysis)
RAA system
• ⊕angiotensin II : Potent vasoconstrictor, ⊕aldosterone, ⊕ACTH,
⊕ADH
• Aldosterone : Reabsorption of Na+ (H2O. K+ and H+ are lost in the
urine in exchange for Na+ )
Hormonal Response
Pituitary Î vasopressin or ADH
• ADH acts on the distal tubule and collecting duct Î
↑H2O permeability, ↓H2O and Na+ losses, and
preserve intravascular volume
• In septic states, endotoxin ⊕ arginine vasopressin
secretion
• Proinflammatory cytokines also contribute to arginine
vasopressin release
• ACE inhibitors Æ Risk of developing hypotension and
vasodilatory shock with open heart surgery
Efferent Signals
Circulatory Homeostasis
Preload
• At rest Æ Major of the blood volume Æ venous system
• Venous return Æ A major determinant of cardiac output
• Most alterations in cardiac output in the normal heart are
related to changes in preload
• ↑Sympathetic tone Æ minor effect on skeletal muscle beds
but produce a dramatic ↓splanchnic blood volume, which
normally holds 20% of the blood volume
• Acute responses to intravascular volume Æ changes in
venous tone, systemic vascular resistance, and intrathoracic
pressure
• Hormonal changes less important in the early response
• Furthermore Æ CO is influenced by ventricular function +
atrial activity & tachycardia.
Efferent Signals
Circulatory Homeostasis
Ventricular Contraction
• The Frank‐Starling curve
• Cardiac dysfunction has been demonstrated in burns
hemorrhagic, traumatic, and septic shock
Afterload
• Afterload Æ Force that resists myocardial contraction
• Arterial pressure is the major component of afterload
• Vascular resistance is determined by precapillary
smooth muscle sphincters & Blood viscosity also ↑
vascular resistance
• ↑Afterload : SV can be maintained by ↑preload
• Stress Æ ⊕ Catecholamines Î↑Contractility + ↑HR
Efferent Signals
Circulatory Homeostasis
Microcirculation
• The microvascular bed is the sympathetic nervous
system
• In hemorrhagic shock Æ Vasoconstriction
• In sepsis or neurogenic shock Æ Vasodilatation
• Recruitment of leukocytes Æ Endothelial cell swelling,
dysfunction and activation Æ ↓capillary perfusion that
may persist after resuscitation
Efferent Signals
Circulatory Homeostasis
Microcirculation
• Shock Æ Failure of the integrity of the endothelium of
the microcirculation Æ capillary leak, intracellular
swelling Æ development of an ECF deficit
• In septic or traumatic shock Æ Capillary dysfunction
(2nd to ⊕ endothelial cells by inflammatory mediators)
Cellular hypoperfusion
Oxygen dept Æ Deficit in tissue oxygenation over time
that occurs during SHOCK
O2 deficit = Estimated O2 demand – Actual O2 consumption
normal Æ cell can “repay” O2 dept during reperfusion
Magnitude of O2 dept Æ Severity & Duration of
hypoperfusion
Measure (O2 dept) Æ Base deficit & Lactate level
Immune and inflammatory
response to shock
TNF-α
y Release
◦ reactive O2 species
◦ lipid-peroxidation products
y redox state
y gene expression
◦ O2 debt is repaid
y Shoemaker's group
y administration of bicarbonate,
hypothermia, hypocapnia
(overventilation), heparin, ethanol, and
ketoacidosis
Gastric tonometry
y To assess perfusion of the GI tract
• Most common cause of shock in the surgical/
trauma patient
• Peripheral vasoconstriction is prominent
• Lack of sympathetic effects on cerebral and
coronary vessels and local autoregulation Æ
promote maintenance of cardiac and CNS
blood flow
Hemorrhagic or Hypovolemic Shock
Diagnosis
• Shock in a trauma patient and postoperative
patient should be presumed to be due to
hemorrhage until proven otherwise
• clinical signs (25 to 30%) Æ significant blood loss
and physiologic decompensation
– agitated patient
– cool clammy extremities
– tachycardia
– weak or absent peripheral pulses
– hypotension
Classification of hemorrhage
Class
Parameter I II III IV
Bl loss(mL) <750 750‐1500 1500‐2000 >2000
Bl loss(%) <15 15‐30 30‐40 >40
HR(bpm) <100 >100 >120 >140
BP Normal Orthostatic Hypotension Severe
hypotension
CNS Normal Anxious Confused Obtunded
symptoms
• Young healthy patients
– vigorous compensatory mechanisms
– tolerate larger volumes of blood loss
– manifesting fewer clinical signs despite the
presence of significant peripheral hypoperfusion
– maintain a near‐normal blood pressure until a
precipitous cardiovascular collapse occurs
• Elderly patients
– Medications
• promote bleeding : warfarin / aspirin
• mask the compensatory responses to bleeding : ß‐
blockers
– atherosclerotic vascular disease
• ↓ cardiac compliance
• inability to elevate HR or cardiac contractility
• ↓tolerate to bleeding
• SBP <110mmHg is a clinically relevant
definition of hypotension and hypoperfusion
based upon an increasing rate of mortality
below this pressure
• Base deficit & Serum lactate
– Both correlate c extent of shock and Pt outcome
– Not firmly correlate c each other
• Serum lactate
– Produced by anaerobic respiration
– Indirect marker
• Tissue hypoperfusion
• Cellular O2 debt
• Severity of hemorrhagic shock
– Predictor of morbidity and mortality with hemorrhage
following trauma
• Base deficit
– Indirect estimation of tissue acidosis
– Severity of base deficit correlates with
• Transfusion requirement
• Multiple organ failure
• Death
– mild : –3 to –5 mmol/L
– moderate : –6 to –9 mmol/L
– severe : < –10 mmol/L
• Potential bleeding sources will be located along
the known or suspected path of the wounding
object
– external
– Intrathoracic
– intra‐abdominal
– retroperitoneal
– long bone fractures
• Nontrauma pt : GI tract must always be
considered as a site for blood loss
External bleeding
• Suspected
– substantial blood loss at the scene
– Hx of massive blood loss from wounds
– visible brisk bleeding
– presence of a large hematoma adjacent to an open
wound
• Injuries to major arteries or veins with associated
open wounds may cause massive blood loss
rapidly
• Direct pressure must be applied and sustained to
minimize ongoing blood loss
Internal bleeding
• Pleural cavity
– 2‐3 L
– Unstable : ICD may be indicated (Therapeutic&Diagnostic)
– Stable : CXR
• Retroperitoneal hemorrhage
– Associated c pelvic fracture
– Confirm by pelvic X‐ray
• Intraperitoneal hemorrhage
– most common source
– PE : insensitive & unreliable
– abdominal distension, abdominal tenderness, visible abdominal
wounds
– Adjunctive tests are essential : US / DPL
Hemorrhagic or Hypovolemic Shock
Treatment
• concurrently with diagnostic evaluation
• NonresponderÆprompt operative
intervention
– ↓time between injury and control of
bleedingÆ↑survival
– Priorities
• (1) secure the airway
• (2) control the source of blood loss
• (3) intravenous volume resuscitation
• Damage control resuscitation
– ERÆORÆICU
– Keep SBP ~ 90 mmHg : prevent renewed bleeding
from recently clotted vessels
– IV resuscitation : Blood products and limited
crystalloids
– Control of hemorrhage is achieved in OR
– Efforts to warm patients and to prevent coagulopathy
using multiple blood products and pharmacologic
agents are used in both OR and ICU.
Uncontrolled hemorrhage
• Delay in surgery Æ ↑mortality
• Attempting to achieve normal BP Æ
↑mortality esp. penetrating injury
• Profound hemodilution should be avoided by
early transfusion of RBC
• SBP goal
– Penetrating : 80‐90 mmHg
– Blunt : 110 mmHg
• Partial responder Æ frequently require
operative intervention
– magnitude and duration of their response will
dictate whether diagnostic maneuvers can be
performed
Hemorrhagic or Hypovolemic Shock
Treatment
• Decompensated / irreversible shock
– fail to respond to resuscitative efforts despite
adequate control of ongoing hemorrhage
– Vasodilation & resistance to vasopressor infusion
• Futile cycle
– uncorrectable hypothermia
– hypoperfusion
– acidosis
– coagulopathy
• Mortality is inevitable
Fluid resuscitation
• Crystalloids : mainstay fluid of choice
• Hypertonic saline
– Immunomodulatory
– ↓Reperfusion‐mediated injury
– ↓ O2 radical formation
– ↓ Impairment of immune fn
– ↓ Brain swelling
– ↓ Total volume used : combat injuries
– ↓ Incidence of ARDS and MOF
• Severe hemorrhage : blood products
– Target Hb 7‐9 g/dL
– FFP : PT/aPTT ratio > 1.5
– Plt : keep > 50 x 109 /L
– Fibrinogen concentrate of Cryoprecipitate : fibrinogen
levels < 1 g/L
• Pharmacologic agents : may have potential benefits
– Recombinant activated coagulation factor7
– Antifibrinolytic agents : ε‐aminocaproic acid, tranexamic
acid (competitive inhibitors of plasmin and plasminogen)
– Aprotinin (protease inhibitor)
Resuscitative adjuncts
• Minimization of heat loss
• Maintaining normothermia
– Hypothermia : acidosis, hypotension,
coagulopathy
TRAUMATIC SHOCK
Traumatic shock
• Combining the effects of soft tissue injury, long bone
fractures, and blood loss
• Proinflammatory activation
– Release of cellular products [Damage associated molecular
patters:DAMPs] Æ Activate cell surface receptors[Pattern
recognition receptors:PRRs]
• Treatment :
– correction of individual elements to diminish the cascade of
proinflammatory activation
– Prompt control of hemorrhage
– Adequate volume resuscitation
– Debridement of nonviable tissue
– Stabilization of bony injuries
– Appropriate treatment of soft tissue injury
VASODILATORY SHOCK
(SEPTIC SHOCK)
Vasodilatory shock
• Result of dysfn of the endothelium and vasculature 2˚
to circulating inflammatory mediators and cells
• Or as a response to prolonged and severe
hypoperfusion
• Failure of the vascular smooth muscle to constrict
appropriately
• characterized by peripheral vasodilation & resistance
to vasopressors
• Represent the final common pathway for profound and
prolonged shock of any etiology
• Mortality rate 30‐50%
Sepsis : systemic response > localized
• Cause of septic and vasodilatory shock
• Findings
– Enhanced cardiac output
– Peripheral vasodilation : iNOS[Potent vasodilator ]
– Fever
– Leukocytosis
– Hyperglycemia
– tachycardia
Vasodilatory shock
Diagnosis
• Sepsis : evidence of an infection
+ systemic signs of inflammation
(fever, leukocytosis, tachycardia)
• Severe sepsis : hypoperfusion with signs of
organ dysfunction
• Septic shock : more significant evidence of
tissue hypoperfusion and systemic
hypotension
Vasodilatory shock
Diagnosis
• Defining the patient at risk
• Aggressive search for infection
– Thorough PE
– Inspection of all wounds
– Evaluation of intravascular catheters or other
foreign bodies
– Appropriate cultures
– Adjunctive imaging studies
Vasodilatory shock
Treatment
• 1st line
– Airway & ventilation
– Fluid resuscitation and restoration of circulatory
volume with balanced salt solutions
– Empiric antibiotics : bacteriologic profile of infections
in an individual unit ,Narrow spectrum
– Source control : infected fluid collections, infected
foreign bodies, and devitalized tissue
• Vasopressor
– Catecholamine : Most often use
– Arginine vasopressin: a potent vasoconstrictor , in
catecholamine resistance
Vasodilatory shock
Treatment
• goal‐directed therapy of septic shock and
severe sepsis
– initiated in the emergency department
– continued for 6 hours
– significantly improved outcome
• higher mean venous O2 saturation
• lower lactate levels
• lower base deficit
• higher pH
• decreased 28‐day mortality
• ↓sudden cardiovascular collapse
• Hyperglycemia
• intensive insulin therapy : maintenance of
blood glucose between 80 and 110 mg/dL
– ↓mortality 42%
– ↓ episodes of septicemia
– ↓ duration of ATB therapy
– ↓ the need for prolonged ventilatory support and
renal replacement therapy
• Acute lung injury & ARDS : lower tidal volume
– ↓ mortality
– ↑ the number of days without ventilator use
• Low tidal volume : 6 mL/kg of predicted BW &
plateau pressure of ≤30 cmH2O
• Traditional : 12 mL/kg of predicted BW and an
airway pressure of 50 cmH2O
• Activated protein C
– endogenous protein that promotes fibrinolysis
and inhibits thrombosis and inflammation
– reduced the 28‐day mortality rate from 31 to 25%
– may not improve mortality when patients are
followed up to 6 months
• Corticosteroids : controversy
CARDIOGENIC SHOCK
• circulatory pump failure leading to diminished
forward flow and subsequent tissue hypoxia
• Hemodynamic criteria
– Hypotension : SBP <90 mmHg for at least 30 min
– ↓Cardiac index : <2.2 L/min/m2
– ↑Pulmonary artery wedge pressure : >15 mmHg
• Mortality rate : 50‐80%
Cardiogenic shock
• 5‐10% of acute MI
• most common cause of death
• 75% develop within 24 hrs after onset of MI
• Optimizing outcome
– Rapid assessment
– Adequate resuscitation
– Reversal of myocardial ischemia
• Prevention of infarct extension is a critical
component
Pathophysiology
Cardiogenic shock
Diagnosis
• Exclude other causes of hypotension
• Cardiac exam
– dysrhythmia
– precordial heave
– distal heart tones
• Confirmation :ECG & urgent echocardiography
• Useful diagnostic tests: CXR, ABG, electrolytes, CBC,
and cardiac enzymes
• Invasive hemodynamic monitoring with a pulmonary
artery catheter may uncover evidence of diminished
cardiac output and elevated pulmonary artery
pressure.
Cardiogenic shock
Diagnosis
• Blunt cardiac injury
– the diagnosis is 2˚ to excluding other etiologies
– Invasive hemodynamic monitoring with a PA
catheter may uncover evidence of ↓COand ↑PA
pressure.
Cardiogenic shock
Treatment
• Preservation of existing myocardium &
preservation of cardiac function
• Adequate airway & ventilation
• Adequate oxygenation Æ adequate myocardial
oxygen delivery
• Avoid fluid overload & pulmonary edema
• Correct E’lyte : hypoK & hypoMg ↓Sympathetic
• Pain Control : IV MO or fentanyl discharge
• Treat significant dysrhythmias and heart block
• Early consultation with cardiologist
Cardiogenic shock
Treatment
• Inotropic drugs : ↑CO&contractility
• Goal
– maximize coronary perfusion
– minimizing myocardial oxygen demand
• Assessment
– Capillary refill
– Character of peripheral pulses
– Urine output
– Laboratory parameters : pH, base deficit, lactate
– Invasive monitoring Æ necessary in unstable patients
• Dobutamine
– ß 1 receptors
• ↑ cardiac output
– ß 2 receptors
• vasodilate peripheral vascular beds
• lower total peripheral resistance
• lower systemic blood pressure
• Dopamine : prefer in hypotensive Pt
tachycardia & ↑TPR may worsen MI
– α receptors : vasoconstriction
– ß1 & ß2 receptors : predominate at lower dose
• Epinephrine
– α& ß receptors
– intense peripheral vasoconstrictor effects Æimpair cardiac
performance
• mechanical circulatory support with an intra‐
aortic balloon pump : Patients refractory to
cardiotonics
– ↑ cardiac output & improves coronary blood flow
by ↓systolic afterload and augmentation of
diastolic perfusion pressure
– No increase in myocardial O2 demand
• Anticoagulant & Aspirin
• ß blockers : control HR and myocardial O2
consumption,
• Nitrates : promote coronary blood flow through
vasodilation
• ACE inhibitors : ↓ ACE‐mediated vasoconstrictive
effects that ↑ myocardial workload and
myocardial O2 consumption
• Although thrombolytic therapy reduces mortality
in patients with acute MI, its role in cardiogenic
shock is less clear
• Current guidelines of the American Heart Association
recommend PTCA for patients with
– cardiogenic shock
– ST elevation
– left bundle‐branch block
– age less than 75 years
• percutaneous transluminal coronary angioplasty
(generally with stent placement) is the treatment of
choice.
• CABG seems to be more appropriate for patients with
multiple vessel disease or left main coronary artery
disease.
OBSTRUCTIVE SHOCK
Most common in Trauma
Obstructive shock
Diagnosis and Treatment
• Tension pneumothorax : should be Dx on clinical
examination (1‐3 sufficient to Dx)
1. respiratory distress (in an awake patient) or hypotension
2. diminished breath sounds
3. hyperresonance to percussion : difficult in noisy area
– jugular venous distention : absent in hypovolemia
– shift of mediastinal structures to the unaffected side
with tracheal deviation : late finding
• Definitive treatment is immediate tube thoracostomy :
4th ICS (nipple level) at the anterior axillary line
• Decompressed with a large caliber needle : emergency
• Tension pneumothorax
• CXR : empiric treatment before film
– deviation of mediastinal structures
– depression of the hemidiaphragm
– hypo‐opacification with absent lung markings
Cardiac temponade
• Accumulation of blood within the pericardial sac
• Limit ventricular filling in diastole Æ ↓CO
• The major determinant of the degree of hypotension is
the pericardial pressure
– Acute : Pericardium does not distend
– Chronic : Fluid may reach 2000 mL
• Any projectile or wounding agent that passes in
proximity to the mediastinum can potentially produce
tamponade
• circulatory arrest require emergency pericardial
decompression, usually through a left thoracotomy
Cardiac temponade
• A high index of suspicion is warranted to make a
rapid diagnosis
• Beck's triad
– hypotension diminished by coexistent bleeding
– neck vein distention
– muffled heart tone : difficult in busy area
• dyspnea, orthopnea, cough, peripheral edema,
chest pain, tachycardia, muffled heart tones,
jugular venous distention, and elevated CVP
• Frequently require additional diagnostic
maneuvers
Cardiac temponade
• Invasive hemodynamic monitoring : help support Dx Æ not specific
– ↑ CVP
– pulsus paradoxus : ↓ systemic arterial pressure with inspiration
– ↑ RA and RV pressure by PA catheter
• Echo : depends on
– skill and experience
– body habitus of the patient
– absence of wounds that preclude visualization of the pericardium
• Pericardiocentesis under US guidance : safer and more reliable
• Diagnostic pericardial window : most direct
– Subxiphoid/Transdiaphragmatic
– Hemodynamics improve dramatically
– Formal pericardial exploration : median sternotomy/Lt anterior
thoracotomy/bilat anterior thoracotomies ("clamshell").
NEUROGENIC SHOCK
Neurogenic shock
• Diminished tissue perfusion as a result of loss
of vasomotor tone to peripheral arterial beds
– ↑ vascular capacitance
– ↓ venous return
– ↓ cardiac output
C/high T‐spine fx Ædisrupt
sympathetic regulation of
peripheral vascular tone
rare
• Sympathetic input to the heart may also be
disruptedÆ preventing the typical reflex
tachycardia
• Activation multiple 2˚ injury mechanisms:
– (a) vascular compromise to the spinal cord with loss
of autoregulation, vasospasm, and thrombosis
– (b) loss of cellular membrane integrity and impaired
energy metabolism
– (c) neurotransmitter accumulation and release of free
radicals
Neurogenic shock
Diagnosis
• bradycardia, hypotension, cardiac dysrhythmias, ↓ CO,
and ↓ PVR
• Severity correlate with the magnitude of
cardiovascular dysfunction
• Pt with complete motor injuries : > 5 times more likely
to require vasopressors
• Classic description of neurogenic shock :
– ↓ BP with bradycardia
– Warm extremities (loss of peripheral vasoconstriction)
– Motor and sensory deficits indicative of a spinal cord
injury
– Radiographic evidence of a vertebral column fracture
• Exclude other causes
Neurogenic shock
Treatment
• Management
– BP control
optimizing perfusion of an
– oxygenation already ischemic spinal cord
– hemodynamics
• Æimproved neurologic outcome
• Pts with hypotension Æ monitor in ICU &
carefully followed for evidence of cardiac /
respiratory dysfunction
Neurogenic shock
Treatment
• Airway and ventilation
• Fluid resuscitation : Most patients with neurogenic
shock will respond to restoration of intravascular
volume alone
• vasoconstrictors
– Only when hypovolemia is excluded & the diagnosis of
neurogenic shock established
– duration of vasopressor support may correlate with the
overall prognosis
– First line : Dopamine
– Unrespond : phenylephrine (pure α agonist)
– 24 to 48 hours
• life‐threatening cardiac dysrhythmias and hypotension
may occur up to 14 days after spinal cord injury
Neurogenic shock
Treatment
• Appropriate rapid restoration of BP and
circulatory perfusion
– improve perfusion to the spinal cord
– prevent progressive spinal cord ischemia
– minimize secondary cord injury
• Restoration of normal blood pressure and
adequate tissue perfusion should precede any
operative attempts to stabilize the vertebral
fracture.